rs144532387
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The NM_201631.4(TGM5):c.1498C>T(p.Arg500Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000254 in 1,614,198 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000046 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000023 ( 0 hom. )
Consequence
TGM5
NM_201631.4 stop_gained
NM_201631.4 stop_gained
Scores
2
2
3
Clinical Significance
Conservation
PhyloP100: 1.09
Genes affected
TGM5 (HGNC:11781): (transglutaminase 5) This gene encodes a member of the transglutaminase family. The encoded protein catalyzes formation of protein cross-links between glutamine and lysine residues, often resulting in stabilization of protein assemblies. This reaction is calcium dependent. Mutations in this gene have been associated with acral peeling skin syndrome. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TGM5 | NM_201631.4 | c.1498C>T | p.Arg500Ter | stop_gained | 10/13 | ENST00000220420.10 | NP_963925.2 | |
TGM5 | NM_004245.4 | c.1252C>T | p.Arg418Ter | stop_gained | 9/12 | NP_004236.1 | ||
TGM5 | XM_011522230.3 | c.469C>T | p.Arg157Ter | stop_gained | 4/7 | XP_011520532.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TGM5 | ENST00000220420.10 | c.1498C>T | p.Arg500Ter | stop_gained | 10/13 | 1 | NM_201631.4 | ENSP00000220420 | P1 | |
TGM5 | ENST00000349114.8 | c.1252C>T | p.Arg418Ter | stop_gained | 9/12 | 1 | ENSP00000220419 | |||
TGM5 | ENST00000396996.3 | n.974C>T | non_coding_transcript_exon_variant | 3/6 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152192Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
7
AN:
152192
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000477 AC: 12AN: 251392Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135866
GnomAD3 exomes
AF:
AC:
12
AN:
251392
Hom.:
AF XY:
AC XY:
6
AN XY:
135866
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1461888Hom.: 0 Cov.: 32 AF XY: 0.0000330 AC XY: 24AN XY: 727244
GnomAD4 exome
AF:
AC:
34
AN:
1461888
Hom.:
Cov.:
32
AF XY:
AC XY:
24
AN XY:
727244
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152310Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74474
GnomAD4 genome
AF:
AC:
7
AN:
152310
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
74474
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
6
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Acral peeling skin syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | The TGM5 c.1498C>T (p.Arg500Ter) variant is a stop-gained variant predicted to result in premature termination of the protein. The p.Arg500Ter variant has been reported in one study in which it is found in a compound heterozygous state with a missense variant in one patient with peeling skin syndrome (van den Velden et al. 2015). Family studies revealed that the patient inherited the p.Arg500Ter variant from the unaffected mother and the second missense variant from the unaffected father. Control data are unavailable for this variant which is reported at a frequency of 0.0001 in the European (non-Finnish) population of the Exome Aggregation Consortium. Based on the evidence and potential impact of stop-gained variants, the p.Arg500Ter variant is classified as a variant of unknown significance but suspicious for pathogenicity for peeling skin syndrome. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Benign
N
MutationTaster
Benign
A;A
Vest4
0.13, 0.13
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at